Vitasora Health Limited (ASX:VHL)
Australia · Delayed Price · Currency is AUD 0.0120
0.00 (0.00%)
Sep 28, 2026, 1:32 PM AEST
Vitasora Health Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 4.84 | 4.84 | 3.71 | 1.04 | 0.66 | 0.77 |
Revenue Growth | -3.41% | 30.63% | 256.78% | 56.85% | -14.26% | -44.29% |
Gross Profit Gross Profit Growth | 4.26 | 4.26 | 3.53 | 1.03 | 0.6 | 0.51 |
Operating Income Operating Income Growth | -10.61 | -10.61 | -10.7 | -7.06 | -5.76 | -6.63 |
Net Income Net Income Growth | -10.61 | -10.61 | -10.7 | -7.13 | -5.78 | -6.62 |
Earnings Per Share EPS Growth | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Medical Devices - Australia Medical Devices - Australia Growth | 0.58 | 0.58 | 0.66 | 0.63 | 0.66 | 0.77 |
Medical Devices - USA Medical Devices - USA Growth | 4.25 | 4.25 | 3.04 | - | - | - |
Corporate Corporate Growth | 0.01 | 0.01 | 0.01 | 0 | 0 | - |
Total Total Growth | 4.84 | 4.84 | 3.71 | 1.04 | 0.66 | 0.77 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 3.08 | 3.08 | 0.42 | 0.79 | 0.17 | 1.25 |
Total Debt Total Debt Growth | - | - | 0.06 | 0.12 | 0.15 | 0.07 |
Net Cash (Debt) Net Cash Growth | 3.08 | 3.08 | 0.36 | 0.67 | 0.03 | 1.18 |
Net Cash Growth | 0.42% | 751.62% | -46.37% | 2545.04% | -97.83% | -85.06% |
Net Cash Per Share Net Cash Per Share Growth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -10 | -10 | -9.17 | -6.64 | -4.49 | -8.48 |
Capital Expenditures CapEx Growth | - | - | - | - | -0.02 | -0 |
Free Cash Flow Free Cash Flow Growth | -10 | -10 | -9.17 | -6.64 | -4.51 | -8.48 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 88.02% | 88.02% | 95.40% | 99.63% | 90.09% | 66.42% |
Operating Margin | -219.22% | -219.22% | -288.81% | -680.22% | -870.00% | -858.74% |
Pretax Margin | -219.22% | -219.22% | -288.81% | -686.48% | -872.26% | -857.85% |
Profit Margin | -219.22% | -219.22% | -288.85% | -686.48% | -872.26% | -857.85% |
FCF Margin | -206.68% | -206.68% | -247.43% | -639.50% | -681.46% | -1098.15% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Forward PE | - | 8.67 | - | - | - | - |
PS Ratio | 5.80 | 5.32 | 16.60 | 27.87 | 48.50 | 54.26 |